dorsaVi (DVL.AX) Aandeel Koers
dorsaVi Koers
De omzet is de afgelopen 16 jaar met 13,7% per jaar gegroeid tot 1,00 Miljoen AUD. De nettowinstmarge van dorsaVi ligt op -849,2% en is ten opzichte van -65,3% enkele jaren eerder gedaald.
dorsaVi aandeelkoers
Deze data ophalen via de Eulerpool API
100.000 requests/maand gratis · geen creditcard
dorsaVi bedrijfsmodel & aandelenanalyse
Veelgestelde vragen over dorsaVi
The business model of dorsaVi Ltd focuses on providing innovative wearable sensor technologies for the healthcare and performance sectors. This Australian company specializes in developing robust and accurate movement analysis solutions that enable real-time data collection and analysis. By leveraging their expertise in biomechanics and software engineering, dorsaVi aims to improve patient outcomes, optimize sports performance, and enhance workplace safety. Their product portfolio includes ViMove, ViSafe, and ViPerform, which offer customized assessments, monitoring, and training solutions for a diverse range of applications. With a strong emphasis on research and development, dorsaVi continues to drive advancements in wearable technology to benefit individuals and organizations globally.
dorsaVi Ltd is primarily active in the healthcare and sports industries.
Some of the main competitors of dorsaVi Ltd in the market include companies such as Vicon Motion Systems Ltd, Xsens Technologies B.V., and Optitrack.
dorsaVi Ltd, a renowned company in the healthcare industry, has an impressive history and background. Founded in 2000 and headquartered in Melbourne, Australia, dorsaVi specializes in wearable sensor technology. The company aims to improve the detection, prevention, and management of musculoskeletal and neurological conditions. dorsaVi's cutting-edge products, such as the ViMove system, offer accurate and objective movement analysis, helping healthcare professionals and patients optimize treatment plans. With a focus on innovation and research, dorsaVi has gained recognition worldwide, collaborating with leading institutions and healthcare providers. By combining technology and healthcare expertise, dorsaVi Ltd continues to drive advancements in patient care and movement analysis.
dorsaVi Ltd is a leading company that has achieved significant milestones in its operations. Some notable achievements include the successful launch of its innovative ViMove technology, which provides accurate and objective motion analysis for healthcare professionals and athletes. The company's partnership with global corporations has also strengthened its market presence and expanded its reach. Additionally, dorsaVi Ltd has received various industry accolades and awards for its groundbreaking solutions and contributions to the healthcare sector. With continuous innovation and a strong focus on enhancing human movement assessment, dorsaVi Ltd continues to cement its position as a pioneering force in the industry.
dorsaVi Ltd primarily operates and serves in several countries and regions worldwide. Some of the key geographical areas where the company is present include Australia, Singapore, United Kingdom, United States, and New Zealand.
dorsaVi Ltd represents transparency, innovation, and a commitment to improving human movement and performance. With a corporate philosophy centered around precision and evidence-based solutions, dorsaVi develops wearable sensor technology that provides valuable insights into biomechanics and neuromuscular control. By combining their expertise in sports science, physiotherapy, and engineering, the company aims to revolutionize the way individuals assess, manage, and enhance their physical abilities. The focus on accurate data collection and analysis enables dorsaVi to empower athletes, healthcare professionals, and everyday individuals with actionable information for injury prevention, performance optimization, and personalized treatment plans.
7 analisten beoordelen het aandeel dorsaVi momenteel: 0 adviseren kopen, 3 houden en 4 verkopen.
Omgezet tegen de huidige wisselkoers noteert het aandeel dorsaVi op 0,01 EUR (0,02 AUD).
Het aandeel dorsaVi (DVL.AX) is genoteerd aan 1 beurzen, waaronder: ASX (DVL.AX).
dorsaVi Ltd is a technology and healthcare company based in Australia with offices worldwide. The company offers a variety of products and services that contribute to improving health, fitness, and performance. The main business of dorsaVi is the development and marketing of solutions for motion analysis and monitoring. The core areas of work are clinical application, sports performance enhancement, and occupational health and safety. The company offers a range of products and services that focus on the goal of optimizing movement. One key component of dorsaVi's solutions is wireless sensors that are attached to various parts of the body. These sensors measure muscle activity, movement direction, and force exertion, among other things. The data collected is analyzed and visualized using appropriate software. The software platform provides differentiated analytics options. As an important part of dorsaVi's service offering, web-based solutions are also available for different target groups. From professional athletes to patients requiring rapid and accurate rehabilitation, the company provides tailored online solutions that are customized to individual needs. However, dorsaVi's solutions are not therapy but exclusively provide effective diagnostics and, accordingly, an objective assessment of therapy progress. One application area for dorsaVi technology, for example, is orthopedic rehabilitation facilities, where the technology supports patients before or after orthopedic surgeries. Additionally, the technology is also used in performance enhancement for professional athletes. The company has specialized in various body areas to offer targeted solutions for specific problems. Whether it is the back, shoulder, knee, or hip area, the portfolio includes numerous products for different issues. Another important business area for dorsaVi is occupational safety and ergonomics. Companies can use motion sensors to monitor their employees' work environment, identifying and eliminating potential risks. The goal is to make workplaces safer and more productive and thus protect employees in the long run. Innovative thinking and a solid value chain make dorsaVi's products and services unique in their outcomes. With a combination of state-of-the-art sensor technology, user-friendly cloud software, and sound movement research, the company has established a leading position in the motion analysis market. dorsaVi's goal is to continuously improve its solutions and thereby maximize the success of its customers.
De omzet van dorsaVi bedraagt 1,00 Miljoen AUD. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.
De winst van dorsaVi bedraagt -8,52 Miljoen AUD. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.
De koers-winstverhouding (P/E) van dorsaVi bedraagt momenteel -2,75. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het dorsaVi-aandeel in te schatten.
De koers-omzetverhouding (P/S) van dorsaVi bedraagt momenteel 23,37. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het dorsaVi-aandeel.
De Eulerpool Kwaliteitsscore voor dorsaVi is 2/10.
De ISIN van dorsaVi is AU000000DVL0. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.
Het tickersymbool van dorsaVi is DVL.AX. Onder dit beurstickersymbool wordt het dorsaVi-aandeel op de beurs verhandeld.
dorsaVi aandeel
dorsaVi Peer Group
dorsaVi Ticker
dorsaVi FIGI
Alle fundamentals en diepgaande analyse van dorsaVi
Onze aandelenanalyse van het dorsaVi-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van dorsaVi. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: